Friday April 03, Barcelona

01.00 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
AVAILABLE INDUSTRY BREAKFAST SYMPOSIUM
08.00 - 09.00
NON-SPONSORED SYMPOSIA
08.00 - 09.00
Gut microbiota (GMB) and osteoarthritis (OA) management: outcomes of an ESCEO experts consensus meeting organized under the auspices of the World Health Organization Collaborating Center for Public Health Aspects of Musculoskeletal Health and Ageing.
Chairpersons: ‣ Islene Araujo de Carvalho, ‣ Sansin Tüzün, ‣ Francis Berenbaum
‣ Introduction Emmanuel Biver
‣ Gut microbiota and inflammation Claudio Franceschi
‣ Role of gut microbiota in non-communicable disease and osteoarthritis management Emmanuel Biver
‣ Discussion Francis Berenbaum
Panel: ‣ Islene Araujo de Carvalho, ‣ Francis Berenbaum, ‣ Emmanuel Biver, ‣ Maria Luisa Brandi, ‣ Philip Calder, ‣ Vincenzo Castronovo, ‣ Etienne Cavalier, ‣ Antonio Cherubini, ‣ Elaine M. Dennison, ‣ Claudio Franceschi, ‣ Nicholas R. Fuggle, ‣ Pierre Miossec, ‣ Jean‑Yves Reginster, ‣ René Rizzoli, ‣ Thierry Thomas, ‣ Sansin Tüzün, ‣ Nicola Veronese
09.00 - 10.30
SCIENTIFIC SESSION I
Chairpersons: ‣ Cyrus Cooper, ‣ René Rizzoli
09.00
Plenary Lecture 1
‣ Transient treatment discontinuation : pros and cons Michael R. McClung
09.30
Oral communication selected from abstracts
10.30 - 12.10
SCIENTIFIC SESSION II
Chairpersons: ‣ Jean‑Yves Reginster, ‣ John A. Kanis
10.30
Presentation of the ESCEO-IOF Herbert Fleisch Medal
‣ René Rizzoli
10.35
Presentation of the IOF President's Award
‣ Cyrus Cooper
10.40
Plenary Lecture 2
‣ Differences in clinical guidelines Eugene McCloskey
11.10
Oral communication selected from abstracts
12.00
Presentation of the ESCEO-AgNovos Healthcare Young Investigator Awards
‣ Jean‑Yves Reginster
14.00 - 15.00
Poster Viewing Session I
14.00 - 15.03
Oral presentation of selected posters
14.00 - 15.00
MEET-THE-EXPERT SESSIONS
Discussion of complex osteoporotic cases
‣ Adolfo Diez‑Perez
Management of CKD-MBD
‣ Jorge Cannata Andia
Nutritional approach of osteoporosis prevention
‣ Stefania Maggi
GIOP : what to do ?
‣ Emmanuel Biver
Pharmacoepidemiology of musculoskeletal disease
‣ Daniel Prieto‑Alhambra
14.00 - 15.00
Alternative treatments for osteoarthritis: stem cells, platelet-rich plasma, autologous chondrocyte transplantation, ...: outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and under the auspices of the International Osteoporosis Foundation (IOF).
Chairpersons: ‣ Willem Lems, ‣ Francis Berenbaum
‣ Introduction and scope of the problem Emmanuel Maheu
‣ Role of surgical regenerative therapies in the management of knee osteoarthritis Richard Oreffo
‣ Role of "alternative" treatments of knee osteoarthritis Nicholas R. Fuggle
‣ Discussion Jean‑François Kaux
Panel: ‣ Francis Berenbaum, ‣ Jaime Branco, ‣ Maria Luisa Brandi, ‣ Olivier Bruyère, ‣ Philip Conaghan, ‣ Cyrus Cooper, ‣ Bernard Cortet, ‣ Maurizio Cutolo, ‣ Nicholas R. Fuggle, ‣ Germain Honvo, ‣ Jean‑François Kaux, ‣ Andrea Laslop, ‣ Willem Lems, ‣ Emmanuel Maheu, ‣ Radmila Matijevic, ‣ Richard Oreffo, ‣ Andrew Price, ‣ Jean‑Yves Reginster, ‣ Roland Roth, ‣ Thierry Thomas, ‣ Nicola Veronese
14.00 - 15.00
Is there a role for MHT in the management of post-menopausal osteoporosis? Outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and under the auspices of the International Osteoporosis Foundation (IOF).
Chairpersons: ‣ Maria Luisa Brandi, ‣ Tim Hillard
‣ Welcome and scope of the problem Antonio Cano
‣ Effects of MHT on bone: What, when, how? Florence Trémollières
‣ Risk/benefit ratio of MHT before and after 60 years Giuseppe Rosano
‣ Discussion (Leader: Serge Rozenberg): All participants of the Working Group
‣ Conclusions Antonio Cano
Panel: ‣ Mylène Aubertin‑Leheudre, ‣ Maria Luisa Brandi, ‣ Antonio Cano, ‣ Peter Collins, ‣ Cyrus Cooper, ‣ Andrea Genazzani, ‣ Nicholas Harvey, ‣ Tim Hillard, ‣ John A. Kanis, ‣ Jean‑Marc Kaufman, ‣ Irene Lambrinoudaki, ‣ Andrea Laslop, ‣ Daniel Prieto‑Alhambra, ‣ Jean‑Yves Reginster, ‣ René Rizzoli, ‣ Giuseppe Rosano, ‣ Serge Rozenberg, ‣ Florence Trémollières
15.00 - 17.00
SCIENTIFIC SESSION III
Chairpersons: ‣ Nicholas Harvey, ‣ Bess Dawson‑Hughes
15.00
Plenary Lecture 3
‣ Bone turnover markers in clinical practice Etienne Cavalier
15.30
Oral communication selected from abstracts
16.30
Plenary Lecture 4
‣ Bone fragility: beyond bone loss Serge Ferrari
15.00 - 16.45
COMMITTEE OF NATIONAL SOCIETIES SPECIAL PLENARY SESSION
‣ Musculoskeletal diseases: diagnosis, management and consequences
Chairpersons: ‣ Philippe Halbout, ‣ Jean‑Yves Reginster, ‣ Famida Jiwa
15.45
Presentation of the IOF Committee of National Societies Medal
‣ Jean‑Yves Reginster